Pharmaceuticals

Drug Development Vaccine Development Drug Discovery Drug Design Cosmetic Enhancement Vaccines Neurological Disorders Patent Protection Clinical Trials AI Innovative Treatments Medical Devices Therapeutic Development Clinical Research Antibodies Agroindustry Market Reactions Vaccine Technology Cosmetic Products Drug Delivery Systems Manufacturing Antivenom Technology Drug Approval

6 ARTICLES

last mo.

Erasca Faces Securities Class Actions After April Patent Claim and Patient Death Disclosures

The suits seek investor damages as courts move to appoint lead plaintiffs and test the company’s disclosure of safety and intellectual‑property risks.

8 ARTICLES

last mo.

2025 Lasker-DeBakey Award Honors Scientists Behind Trikafta’s Cystic Fibrosis Breakthrough

7 ARTICLES

this yr.

Commerce Department Weighs Annual 1–5% Tax on Patent Valuations

Pharmaceuticals

Erasca Faces Securities Class Actions After April Patent Claim and Patient Death Disclosures

First Patient Dosed in Human Trial for Cell 'Rejuvenation' Therapy

Regeneron Strikes Parabilis Deal to Develop Antibody-Helicon Drugs

Cornell Study Shows Reversible Male Contraception by Targeting Meiosis in Mice

Mushrooms Evolved Psilocybin Two Ways, Lab Study Confirms

Cambridge Researchers Demonstrate Tumor-Triggered Two-Part STING Prodrug

2025 Lasker-DeBakey Award Honors Scientists Behind Trikafta’s Cystic Fibrosis Breakthrough

Commerce Department Weighs Annual 1–5% Tax on Patent Valuations